{"nct_id":"NCT02837380","title":"A Phase I Pharmacokinetic Study of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 Microgram [mcg]) After Single and Repeat Dose Administration From a Dry Powder Inhaler in Healthy Chinese Subjects","status":"COMPLETED","status_verified_date":"2017-01","start_date":"2016-09","start_date_type":null,"primary_completion_date":"2016-11","primary_completion_date_type":"ACTUAL","completion_date":"2016-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}